Beijing Science Sun Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300485.SZ

Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2023: USD 3.08 M

Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill is USD 3.08 M for the year ending December 31, 2023, a -2.80% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 3.17 M, a -7.92% change year over year.
  • Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 3.44 M, a 2.73% change year over year.
  • Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 3.35 M, a 6.69% change year over year.
  • Beijing Science Sun Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 3.14 M, a -1.24% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300485.SZ

Beijing Science Sun Pharmaceutical Co., Ltd.

CEO Mr. Biao Ma
IPO Date June 26, 2015
Location China
Headquarters No.8, Xingsheng Street
Employees 532
Sector Healthcare
Industries
Description

Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.

StockViz Staff

February 2, 2025

Any question? Send us an email